Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial–Mesenchymal Transition Process
Sureerat Padthaisong(Khon Kaen University), Watcharin Loilome(Khon Kaen University)
Cited by 24
Related Papers
PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma
|International Journal of Cancer|2010|60
Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells
|Oncology Reports|2016|40
CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression
|PLoS ONE|2021|19